In vivo tracking of th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue

Journal of Nuclear Medicine

Volumn 55, Issue 2, 2014, Pages 301-307

  Griessinger, Christoph M ^a   Kehlbach, Rainer ^a   Bukala, Daniel ^a   Wiehr, Stefan ^a   Bantleon, Rüdiger ^a   Cay, Funda ^a   Schmid, Andreas ^a   Braumüller, Heidi ^a   Fehrenbacher, Birgit ^a   Schaller, Martin ^a   Eichner, Martin ^a   Sutcliffe, Julie L ^b   Ehrlichmann, Walter ^a   Eibl, Oliver ^a   Reischl, Gerald ^a   Cherry, Simon R ^b   Röcken, Martin ^a   Pichler, Bernd J ^a   Kneilling, Manfred ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b University of California   (United States)

Author keywords

In vivo cell tracking; Murine Th1 cells; Small animal PET

Indexed keywords

COPPER PYRUVALDEHYDE BIS(N 4 METHYLTHIOSEMICARBAZONE) CU 44; GAMMA INTERFERON; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; COPPER; COPPER PYRUVALDEHYDE BIS(N(4) METHYLTHIOSEMICARBAZONE) COMPLEX; COPPER PYRUVALDEHYDE BIS(N(4)-METHYLTHIOSEMICARBAZONE) COMPLEX; DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND; PEPTIDE; THIOSEMICARBAZONE DERIVATIVE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; CD4+ T LYMPHOCYTE; CELL FATE; CELL LABELING; CELL VIABILITY; CELLULAR DISTRIBUTION; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA STRAND BREAKAGE; DRUG ACCUMULATION; EYE TRACKING; FLUORESCENCE ACTIVATED CELL SORTING; IN VIVO STUDY; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; X RAY ANALYSIS; 64CU-PTSM; ANIMAL; AUTOIMMUNITY; CELL MOTION; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DOUBLE STRANDED DNA BREAK; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOTHERAPY; IN VIVO CELL TRACKING; LYMPH NODE; METABOLISM; METHODOLOGY; MURINE TH1 CELLS; PATHOLOGY; SCINTISCANNING; SMALL ANIMAL PET; TIME; TISSUE DISTRIBUTION;

64CU-PTSM; IN VIVO CELL TRACKING; MURINE TH1 CELLS; SMALL ANIMAL PET;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; COPPER RADIOISOTOPES; DNA BREAKS, DOUBLE-STRANDED; FLOW CYTOMETRY; IMMUNOTHERAPY; INTERFERON-GAMMA; LYMPH NODES; LYMPHOID TISSUE; MICE; ORGANOMETALLIC COMPOUNDS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; TH1 CELLS; THIOSEMICARBAZONES; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84897947596     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.126318     Document Type: Article

References (38)

1. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14: 459-465.
2. Cherry SR. Fundamentals of positron emission tomography and applications in preclinical drug development. J Clin Pharmacol. 2001;41: 482-491.
3. Constantinescu CC, Mukherjee J. Performance evaluation of an Inveon PET preclinical scanner. Phys Med Biol. 2009;54: 2885-2899.
4. Yaghoubi SS, Creusot RJ, Ray P, Fathman CG, Gambhir SS. Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice: image-based estimation of the number of cells accumulating in mouse paws. J Biomed Opt. 2007;12: 064025.
5. Thu MS, Bryant LH, Coppola T, et al. Self-Assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med. 2012;18: 463-467.
6. Matsui K, Wang Z, McCarthy TJ, Allen PM, Reichert DE. Quantitation and visualization of tumor-specific T cells in the secondary lymphoid organs during and after tumor elimination by PET. Nucl Med Biol. 2004;31: 1021-1031.
7. Ray P, Tsien R, Gambhir SS. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res. 2007;67: 3085-3093.
8. 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA. 2002;99: 3030-3035.
9. Nair-Gill ED, Shu CJ, Radu CG, Witte ON. Non-invasive imaging of adaptive immunity using positron emission tomography. Immunol Rev. 2008;221: 214-228.
10. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol. 1996;23: 957-980.
11. Biesemeier A, Schraermeyer U, Eibl O. Quantitative chemical analysis of ocular melanosomes in stained and non-stained tissues. Micron. 2011;42: 461-470.
12. Eibl O, Schultheiss S, Blitgen-Heinecke P, Schraermeyer U. Quantitative chemical analysis of ocular melanosomes in the TEM. Micron. 2006;37: 262-276.
13. Parente-Pereira AC, Burnet J, Ellison D, et al. Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice. J Clin Immunol. 2011;31: 710-718.
14. Prince HM, Wall DM, Ritchie D, et al. In vivo tracking of dendritic cells in patients with multiple myeloma. J Immunother. 2008;31: 166-179.
15. Torjman MC, Joseph JI, Munsick C, Morishita M, Grunwald Z. Effects of isoflurane on gastrointestinal motility after brief exposure in rats. Int J Pharm. 2005;294: 65-71.
16. 18F]FLT) uptake in animal models of cancer and inflammation. Mol Imaging. 2013;12: 277-287.
17. Schipf A, Heilmann A, Boue L, Mossmann H, Brocker T, Rocken M. Th2 cells shape the differentiation of developing T cell responses during interactions with dendritic cells in vivo. Eur J Immunol. 2003;33: 1697-1706.
18. Ziegler A, Heidenreich R, Braumuller H, et al. EpCAM, a human tumor-Associated antigen promotes Th2 development and tumor immune evasion. Blood. 2009;113: 3494-3502.
19. Müller-Hermelink N, Braumuller H, Pichler B, et al. TNFR1 signaling and IFNgamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell. 2008;13: 507-518.
20. Besser MJ, Shapira-Frommer R, Treves AJ, et al. Clinical responses in a phase II study using adoptive transfer of short-Term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2010;16: 2646-2655.
21. Rosenberg SA. Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know. Nat Rev Clin Oncol. 2011;8: 577-585.
22. Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. 2012;12: 269-281.
23. Braumüller H, Wieder T, Brenner E, et al. T-helper-1-cell cytokines drive cancer into senescence. Nature. 2013;494: 361-365.
24. Wu AM, Senter PD. Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol. 2005;23: 1137-1146.
25. 64Cu-labeled antibodies against native cell-Adherent PSMA. Prostate. 2010;70: 1413-1421.
26. 111In-oxineand Tc-99m-hexamethylpropylene amine oxime-labeled leukocyte imaging. Clin Nucl Med. 2011;36: e50-e56.
27. 111In-oxine: Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010; 37: 835-841.
28. Gildehaus FJ, Haasters F, Drosse I, et al. Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-Tracking using SPECT/CT in vivo. Mol Imaging Biol. 2011;13: 1204-1214.
29. 19F MRI for quantitative in vivo cell tracking. Trends Biotechnol. 2010;28: 363-370.
30. Halin C, Mora JR, Sumen C, von Andrian UH. In vivo imaging of lymphocyte trafficking. Annu Rev Cell Dev Biol. 2005;21: 581-603.
31. Kircher MF, Allport JR, Graves EE, et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 2003;63: 6838-6846.
32. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol. 2005;23: 983-987.
33. 19F MRI. Magn Reson Med. 2009; 62: 747-753.
34. Kircher MF, Gambhir SS, Grimm J. Noninvasive cell-Tracking methods. Nat Rev Clin Oncol. 2011;8: 677-688.
35. Adelstein SJ, Merrill C. Sosman Lecture. The Auger process: a therapeutic promise? AJR. 1993;160: 707-713.
36. Lewis J, Laforest R, Buettner T, et al. Copper-64-diacetyl-bis(N4- methylthiosemicarbazone): an agent for radiotherapy. Proc Natl Acad Sci USA. 2001;98: 1206-1211.
37. Klinkert WE. Homing of antigen-specific T cells in the Lewis rat. I. Accumulation of antigen-reactive cells in the perithymic lymph nodes. J Immunol. 1987;139: 1030-1036.
38. Mannheim JG, Judenhofer MS, Schmid A, et al. Quantification accuracy and partial volume effect in dependence of the attenuation correction of a state-ofthe-Art small animal PET scanner. Phys Med Biol. 2012;57: 3981-3993.